You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Full-Court Press: Talking to Patients About Psoriasis in Sensitive Areas

  • Authors: Melinda Gooderham, MD, MSc, FRCPC
  • CME Released: 3/10/2023
  • Valid for credit through: 3/10/2024
Start Activity

  • Credits Available

    Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for dermatologists, primary care physicians, rheumatologists, physician assistants, and other clinicians who treat patients with psoriasis.

The goal of this activity is for learners to be better able to discuss the impact of psoriasis in sensitive areas with patients and develop treatment plans.

Upon completion of this activity, participants will:

  • Demonstrate improved performance associated with
    • Discussing the impact of psoriasis in sensitive areas with patients
    • Developing a treatment plan for patients with psoriasis in sensitive areas


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Melinda Gooderham, MD, MSc, FRCPC

    Assistant Professor
    Department of Medicine
    Queen's University
    Consultant Physician
    Peterborough Regional Health Centre
    Medical Director
    SKiN Centre for Dermatology
    Peterborough, Ontario, Canada

    Disclosures

    Melinda Gooderham, MD, MSc, FRCPC, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie Inc.; Akros Pharma Inc.; Amgen Inc.; AnaptysBio, Inc.; Arcutis Biotherapeutics, Inc.; Aristea Therapeutics; Asana BioSciences, LLC; Aslan Pharmaceuticals; Bausch Health Companies Inc.; Boehringer Ingelheim International GmbH; Celgene Corporation; Eli Lilly and Company; Galderma S.A.; Janssen Biotech, Inc.; Kyowa Kirin Pharmaceutical Development, Inc.; LEO Pharma, Inc.; Novartis Pharmaceuticals; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi Genzyme; Sun Pharmaceutical Industries, Ltd.; UCB Pharma, Inc.
    Speaker or member of speakers bureau for: AbbVie Inc.; Amgen Inc.; Arcutis Biotherapeutics, Inc.; Aslan Pharmaceuticals; Bausch Health Companies Inc.; Boehringer Ingelheim International GmbH; Celgene Corporation; Eli Lilly and Company; Galderma S.A.; Janssen Biotech, Inc.; LEO Pharma, Inc.; Novartis Pharmaceuticals; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi Genzyme; Sun Pharmaceutical Industries, Ltd.; UCB Pharma, Inc.
    Research funding from: AbbVie Inc.; Akros Pharma Inc.; Amgen Inc.; AnaptysBio, Inc.; Arcutis Biotherapeutics, Inc.; Aristea Therapeutics; Aslan Pharmaceuticals; Bausch Health Companies Inc.; Boehringer Ingelheim International GmbH; Bristol Myers Squibb Company; Celgene Corporation; Coherus BioSciences; Dermira Inc.; Eli Lilly and Company; Galderma S.A.; GlaxoSmithKline; Incyte Corporation; Janssen Biotech, Inc.; Kyowa Kirin Pharmaceutical Development, Inc.; LEO Pharma, Inc.; MedImmune Inc.; Merck & Co., Inc.; MoonLake Immunotherapeutics; Nimbus Therapeutics; Novartis Pharmaceuticals; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi Genzyme; Sun Pharmaceutical Industries, Ltd.; UCB Pharma, Inc.

Editors

  • Karen Badal, MD, MPH

    Senior Medical Education Director, Medscape, LLC

    Disclosures

    Karen Badal, MD, MPH, has no relevant financial relationships.

  • Ashley Stumvoll, MRes

    Associate Medical Writer, Medscape, LLC

    Disclosures

    Ashley Stumvoll, MRes, has no relevant financial relationships.

Compliance Reviewer

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Full-Court Press: Talking to Patients About Psoriasis in Sensitive Areas

Authors: Melinda Gooderham, MD, MSc, FRCPCFaculty and Disclosures

CME Released: 3/10/2023

Valid for credit through: 3/10/2024

processing....

A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

  • Print